chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: red itchy clusters on the left arm on the opposite side of elbow around 2 weeks; Itchy; clusters developed as little bumps; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (red itchy clusters on the left arm on the opposite side of elbow around 2 weeks), PRURITUS (Itchy) and SWELLING (clusters developed as little bumps) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 025B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROCHLOROTHIAZIDE and METOPROLOL for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (red itchy clusters on the left arm on the opposite side of elbow around 2 weeks) and SWELLING (clusters developed as little bumps). an unknown date, the patient experienced PRURITUS (Itchy). The patient was treated with MOMETASONE FUROATE at an unspecified dose and frequency. At the time of the report, ERYTHEMA (red itchy clusters on the left arm on the opposite side of elbow around 2 weeks), PRURITUS (Itchy) and SWELLING (clusters developed as little bumps) outcome was unknown. Not Provided
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia, Vaccination complication
Clinical narrative: "Felt sick for a day or two after dose #2; chills; Slight fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION ("Felt sick for a day or two after dose #2), CHILLS (chills), PYREXIA (Slight fever) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Osteoporosis in 2020. Concomitant products included RISEDRONATE SODIUM (ACTONEL), ECHINACEA PURPUREA, FISH OIL, MULTIVITAMINS [VITAMINS NOS], CALCIUM, COLECALCIFEROL (CALCIUM WITH D3) and CYANOCOBALAMIN (B12-VITAMIIN) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (Slight fever) and HEADACHE (Headache). On an unknown date, the patient experienced VACCINATION COMPLICATION ("Felt sick for a day or two after dose #2). The patient was treated with PARACETAMOL (TYLENOL EXTRA-STRENGTH) (oral) for Headache and Slight fever, at an unspecified dose and frequency. On 14-Mar-2021, CHILLS (chills), PYREXIA (Slight fever) and HEADACHE (Headache) had resolved. At the time of the report, VACCINATION COMPLICATION ("Felt sick for a day or two after dose #2) outcome was unknown. Not Provided          This case was linked to MOD-2021-020677 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: added patient medical history , added concomitant and treatment medications, updated events outcome; Sender's Comments:  MOD-2021-020677:1st dose case
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: one week later, swelling of lymph node under the armpit of the injection site; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (one week later, swelling of lymph node under the armpit of the injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (one week later, swelling of lymph node under the armpit of the injection site). At the time of the report, LYMPHADENOPATHY (one week later, swelling of lymph node under the armpit of the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included birth control pills. No treatment information provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Vaccination site movement impairment, Vaccination site pain
Clinical narrative: Its painful when she moves; Burning pain in that area; sharp pain on the injection site arm./not very close to injection site/repeatedly was progressing worse/it has significant burning pain; If she turns her head, there is pain in her shoulder; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Its painful when she moves), BURNING SENSATION (Burning pain in that area), VACCINATION SITE PAIN (sharp pain on the injection site arm./not very close to injection site/repeatedly was progressing worse/it has significant burning pain) and ARTHRALGIA (If she turns her head, there is pain in her shoulder) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Its painful when she moves), BURNING SENSATION (Burning pain in that area), VACCINATION SITE PAIN (sharp pain on the injection site arm./not very close to injection site/repeatedly was progressing worse/it has significant burning pain) and ARTHRALGIA (If she turns her head, there is pain in her shoulder). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Its painful when she moves), BURNING SENSATION (Burning pain in that area), VACCINATION SITE PAIN (sharp pain on the injection site arm./not very close to injection site/repeatedly was progressing worse/it has significant burning pain) and ARTHRALGIA (If she turns her head, there is pain in her shoulder) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: missed dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed dose) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: nurse inadvertently administered 1ml instead of 0.5ml; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (nurse inadvertently administered 1ml instead of 0.5ml) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced ACCIDENTAL OVERDOSE (nurse inadvertently administered 1ml instead of 0.5ml). On 27-Apr-2021, ACCIDENTAL OVERDOSE (nurse inadvertently administered 1ml instead of 0.5ml) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.    This case was linked to MODERNATX, INC.-MOD-2021-092190, MOD21-083125 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-092190: MOD21-083125:
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Vaccination complication
Clinical narrative: Patient wasn't able to receive second dose within recommended interval; Patient was in and out of hospital due to certain conditions after receiving first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient wasn't able to receive second dose within recommended interval) and VACCINATION COMPLICATION (Patient was in and out of hospital due to certain conditions after receiving first dose) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient wasn't able to receive second dose within recommended interval) and VACCINATION COMPLICATION (Patient was in and out of hospital due to certain conditions after receiving first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient wasn't able to receive second dose within recommended interval) and VACCINATION COMPLICATION (Patient was in and out of hospital due to certain conditions after receiving first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Malaise, Pruritus, Rash, Rash erythematous
Clinical narrative: started to develop rash around the knee and the back of the knee, elbow / spread up the leg and hands; small red itchy bumps, not in clusters but close together; itchy bumps; rash spread up the leg and hands; swelling of lymph node; got really sick the whole day; wasn't well; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got really sick the whole day), MALAISE (wasn't well), RASH (started to develop rash around the knee and the back of the knee, elbow / spread up the leg and hands), RASH ERYTHEMATOUS (small red itchy bumps, not in clusters but close together) and PRURITUS (itchy bumps) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced MALAISE (wasn't well). On an unknown date, the patient experienced ILLNESS (got really sick the whole day), RASH (started to develop rash around the knee and the back of the knee, elbow / spread up the leg and hands), RASH ERYTHEMATOUS (small red itchy bumps, not in clusters but close together), PRURITUS (itchy bumps), RASH (rash spread up the leg and hands) and SWELLING (swelling of lymph node). At the time of the report, ILLNESS (got really sick the whole day), MALAISE (wasn't well), RASH (started to develop rash around the knee and the back of the knee, elbow / spread up the leg and hands), RASH ERYTHEMATOUS (small red itchy bumps, not in clusters but close together), PRURITUS (itchy bumps) and SWELLING (swelling of lymph node) outcome was unknown and RASH (rash spread up the leg and hands) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-092541 (Patient Link).
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: started to develop rash around the knee and the back of the knee, elbow / spread up the leg and hands; small red itchy bumps, not in clusters but close together; itchy bumps; rash spread up the leg and hands; swelling of lymph node; got really sick the whole day; wasn't well; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got really sick the whole day), MALAISE (wasn't well), RASH (started to develop rash around the knee and the back of the knee, elbow / spread up the leg and hands), RASH ERYTHEMATOUS (small red itchy bumps, not in clusters but close together) and PRURITUS (itchy bumps) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced MALAISE (wasn't well). On an unknown date, the patient experienced ILLNESS (got really sick the whole day), RASH (started to develop rash around the knee and the back of the knee, elbow / spread up the leg and hands), RASH ERYTHEMATOUS (small red itchy bumps, not in clusters but close together), PRURITUS (itchy bumps), RASH (rash spread up the leg and hands) and SWELLING (swelling of lymph node). At the time of the report, ILLNESS (got really sick the whole day), MALAISE (wasn't well), RASH (started to develop rash around the knee and the back of the knee, elbow / spread up the leg and hands), RASH ERYTHEMATOUS (small red itchy bumps, not in clusters but close together), PRURITUS (itchy bumps) and SWELLING (swelling of lymph node) outcome was unknown and RASH (rash spread up the leg and hands) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-092541 (Patient Link).
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal distension, Abdominal pain upper, Chills, Flatulence, Nausea
Clinical narrative: stomach cramps; gas all in the upper abdomen; bloated; nausea; chills; shaking; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR, ABDOMINAL PAIN UPPER (stomach cramps), FLATULENCE (gas), ABDOMINAL DISTENSION (bloated), and NAUSEA in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 08-Apr-2021, the patient experienced TREMOR and CHILLS. On 09-Apr-2021, the patient experienced NAUSEA. On 10-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach cramps), FLATULENCE (gas) and ABDOMINAL DISTENSION (bloated). On 08-Apr-2021, TREMOR and CHILLS had resolved. On 10-Apr-2021, NAUSEA had resolved. At the time of the report, ABDOMINAL PAIN UPPER (stomach cramps), FLATULENCE (gas) and ABDOMINAL DISTENSION (bloated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: stomach cramps; gas all in the upper abdomen; bloated; nausea; chills; shaking; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR, ABDOMINAL PAIN UPPER (stomach cramps), FLATULENCE (gas), ABDOMINAL DISTENSION (bloated), and NAUSEA in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 08-Apr-2021, the patient experienced TREMOR and CHILLS. On 09-Apr-2021, the patient experienced NAUSEA. On 10-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach cramps), FLATULENCE (gas) and ABDOMINAL DISTENSION (bloated). On 08-Apr-2021, TREMOR and CHILLS had resolved. On 10-Apr-2021, NAUSEA had resolved. At the time of the report, ABDOMINAL PAIN UPPER (stomach cramps), FLATULENCE (gas) and ABDOMINAL DISTENSION (bloated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested positive for covid 19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for covid 19) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for covid 19). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for covid 19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Apr-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported Treatment medication was not provided
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: 8 by 8 rash on the top of the buttocks area in lower back; This spontaneous case was reported by a consumer and describes the occurrence of RASH (8 by 8 rash on the top of the buttocks area in lower back) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 046B21A) for COVID-19 vaccination.     Concurrent medical conditions included HIV positive and Bradycardia. Concomitant products included BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY), ROPINIROLE, ALPRAZOLAM, GABAPENTIN, NAPROXEN, CITALOPRAM and OXCARBAZEPINE for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced RASH (8 by 8 rash on the top of the buttocks area in lower back). The patient was treated with BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE (CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE) for Rash, at an unspecified dose and frequency. At the time of the report, RASH (8 by 8 rash on the top of the buttocks area in lower back) outcome was unknown. Not Provided
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Feeling hot, Lethargy, Myalgia
Clinical narrative: Extraordinarily lethargy; loss of appetite; warm temperature with no fever; body aches,"felt like someone hit me with a baseball bat in the art; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Extraordinarily lethargy), DECREASED APPETITE (loss of appetite), FEELING HOT (warm temperature with no fever) and MYALGIA (body aches,"felt like someone hit me with a baseball bat in the art) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in February 2020. Concurrent medical conditions included CYP450 2D6 ultrarapid metaboliser status.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced LETHARGY (Extraordinarily lethargy), DECREASED APPETITE (loss of appetite), FEELING HOT (warm temperature with no fever) and MYALGIA (body aches,"felt like someone hit me with a baseball bat in the art). On 12-Apr-2021, LETHARGY (Extraordinarily lethargy), DECREASED APPETITE (loss of appetite), FEELING HOT (warm temperature with no fever) and MYALGIA (body aches,"felt like someone hit me with a baseball bat in the art) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Concomitant medication included blood thinner. Treatment medication included Tylenol 1000 mg.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, COVID-19, Cough, Myalgia
Clinical narrative: more asthma than before; body ache; Symptoms of COVID-19; cough; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Symptoms of COVID-19), COUGH (cough), ASTHMA (more asthma than before) and MYALGIA (body ache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Gastritis and Drug allergy (Patient is allergic to Aspirin). Concomitant products included PROBIOTICS NOS for Gastritis, VITAMINS NOS for an unknown indication.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced COVID-19 (Symptoms of COVID-19) and COUGH (cough). On an unknown date, the patient experienced ASTHMA (more asthma than before) and MYALGIA (body ache). At the time of the report, COVID-19 (Symptoms of COVID-19), COUGH (cough), ASTHMA (more asthma than before) and MYALGIA (body ache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-092618 (Patient Link).
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Bacterial test, Chills, Cough, Feeling abnormal, Nausea
Clinical narrative: cough; sore throat; Postnasal drip; nausea,; Chills; did not feel good for 24 hours; arm hurt (8/10 pain scale); This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (arm hurt (8/10 pain scale)), COUGH (cough), OROPHARYNGEAL PAIN (sore throat), FEELING ABNORMAL (did not feel good for 24 hours) and UPPER-AIRWAY COUGH SYNDROME (Postnasal drip) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm hurt (8/10 pain scale)), FEELING ABNORMAL (did not feel good for 24 hours), NAUSEA (nausea,) and CHILLS (Chills). On 17-Apr-2021, the patient experienced COUGH (cough), OROPHARYNGEAL PAIN (sore throat) and UPPER-AIRWAY COUGH SYNDROME (Postnasal drip). At the time of the report, PAIN IN EXTREMITY (arm hurt (8/10 pain scale)), COUGH (cough), OROPHARYNGEAL PAIN (sore throat), FEELING ABNORMAL (did not feel good for 24 hours), UPPER-AIRWAY COUGH SYNDROME (Postnasal drip), NAUSEA (nausea,) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain in extremity, SARS-CoV-2 test, Upper-airway cough syndrome
Clinical narrative: cough; sore throat; Postnasal drip; nausea,; Chills; did not feel good for 24 hours; arm hurt (8/10 pain scale); This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (arm hurt (8/10 pain scale)), COUGH (cough), OROPHARYNGEAL PAIN (sore throat), FEELING ABNORMAL (did not feel good for 24 hours) and UPPER-AIRWAY COUGH SYNDROME (Postnasal drip) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm hurt (8/10 pain scale)), FEELING ABNORMAL (did not feel good for 24 hours), NAUSEA (nausea,) and CHILLS (Chills). On 17-Apr-2021, the patient experienced COUGH (cough), OROPHARYNGEAL PAIN (sore throat) and UPPER-AIRWAY COUGH SYNDROME (Postnasal drip). At the time of the report, PAIN IN EXTREMITY (arm hurt (8/10 pain scale)), COUGH (cough), OROPHARYNGEAL PAIN (sore throat), FEELING ABNORMAL (did not feel good for 24 hours), UPPER-AIRWAY COUGH SYNDROME (Postnasal drip), NAUSEA (nausea,) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Swelling face, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot to touch at injection site; Facial swelling; Rapid heart beat; arm swollen and hot to touch at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to touch at injection site), SWELLING FACE (Facial swelling), HEART RATE INCREASED (Rapid heart beat) and VACCINATION SITE SWELLING (arm swollen and hot to touch at injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Hot to touch at injection site), SWELLING FACE (Facial swelling), HEART RATE INCREASED (Rapid heart beat) and VACCINATION SITE SWELLING (arm swollen and hot to touch at injection site). At the time of the report, VACCINATION SITE WARMTH (Hot to touch at injection site), SWELLING FACE (Facial swelling), HEART RATE INCREASED (Rapid heart beat) and VACCINATION SITE SWELLING (arm swollen and hot to touch at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant medication not provided.  Treatment information not provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Intentional product use issue
Clinical narrative: patient out of recommended dosing window more than 48 days; This spontaneous case was reported by a pharmacist and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (patient out of recommended dosing window more than 48 days) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced INTENTIONAL PRODUCT USE ISSUE (patient out of recommended dosing window more than 48 days). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (patient out of recommended dosing window more than 48 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: F/U Received, Contact information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Fatigue, Herpes zoster, Pain
Clinical narrative: aggravated flare up of shingles; mild shock in back, intense nerve activity in the back; burning and stinging in the back; burning and stinging in the back; Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (aggravated flare up of shingles), PAIN (mild shock in back, intense nerve activity in the back), BURNING SENSATION (burning and stinging in the back), PAIN (burning and stinging in the back) and FATIGUE (Felt tired) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced HERPES ZOSTER (aggravated flare up of shingles), PAIN (mild shock in back, intense nerve activity in the back), BURNING SENSATION (burning and stinging in the back), PAIN (burning and stinging in the back) and FATIGUE (Felt tired). At the time of the report, HERPES ZOSTER (aggravated flare up of shingles), PAIN (mild shock in back, intense nerve activity in the back), BURNING SENSATION (burning and stinging in the back), PAIN (burning and stinging in the back) and FATIGUE (Felt tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Felt run down & tired; soreness in arm from the shot; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Felt run down & tired) and PAIN IN EXTREMITY (soreness in arm from the shot) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     The patient's past medical history included Neck surgery (neck fusion).   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced FATIGUE (Felt run down & tired) and PAIN IN EXTREMITY (soreness in arm from the shot). At the time of the report, FATIGUE (Felt run down & tired) and PAIN IN EXTREMITY (soreness in arm from the shot) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  This case was linked to MOD-2021-092640 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Updated additional contact information to previous case.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash has more than 6 episodes; This spontaneous case was reported by a physician and describes the occurrence of RASH (rash has more than 6 episodes) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash has more than 6 episodes). At the time of the report, RASH (rash has more than 6 episodes) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itchy at injection site; Tiny rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE RASH (Tiny rash at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE RASH (Tiny rash at injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE RASH (Tiny rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Fatigue, Feeling abnormal, Headache, Myalgia
Clinical narrative: brain is not clear; Asthma; headache; body ache; Tired; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (brain is not clear), ASTHMA (Asthma), HEADACHE (headache), MYALGIA (body ache) and FATIGUE (Tired) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma, Gastritis and Drug allergy (Aspirin). Concomitant products included PROBIOTICS NOS for Gastritis.  On 25-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, the patient experienced FATIGUE (Tired) and PYREXIA (Fever). On an unknown date, the patient experienced FEELING ABNORMAL (brain is not clear), ASTHMA (Asthma), HEADACHE (headache) and MYALGIA (body ache). At the time of the report, FEELING ABNORMAL (brain is not clear), ASTHMA (Asthma), HEADACHE (headache), MYALGIA (body ache), FATIGUE (Tired) and PYREXIA (Fever) outcome was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-092588 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: brain is not clear; Asthma; headache; body ache; Tired; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (brain is not clear), ASTHMA (Asthma), HEADACHE (headache), MYALGIA (body ache) and FATIGUE (Tired) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma, Gastritis and Drug allergy (Aspirin). Concomitant products included PROBIOTICS NOS for Gastritis.  On 25-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, the patient experienced FATIGUE (Tired) and PYREXIA (Fever). On an unknown date, the patient experienced FEELING ABNORMAL (brain is not clear), ASTHMA (Asthma), HEADACHE (headache) and MYALGIA (body ache). At the time of the report, FEELING ABNORMAL (brain is not clear), ASTHMA (Asthma), HEADACHE (headache), MYALGIA (body ache), FATIGUE (Tired) and PYREXIA (Fever) outcome was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-092588 (Patient Link).
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation
Clinical narrative: Burning sensation; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning sensation) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041821A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced BURNING SENSATION (Burning sensation). At the time of the report, BURNING SENSATION (Burning sensation) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. No treatment was reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: swelling in her feet; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling in her feet) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced PERIPHERAL SWELLING (swelling in her feet). At the time of the report, PERIPHERAL SWELLING (swelling in her feet) outcome was unknown.            Concomitant product use was not provided. No treatment was reported. Action taken in response to mRNA-1273 was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Updated patient demographics, added vaccine information(second dose) and added a new event.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Dyspnoea, Erythema, Localised infection
Clinical narrative: Lymphedema on his right arm; Neck muscle pain.It is a constant lingering pain; Couldnt turn or raise his head up and down; Back of his neck got really sore; Arm was sore at injection site; Had a fever; Chills; Right arm became badly infected "It was a major infection"; Arm was swollen; Arm was red; Dizziness; Couldnt breathe; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHOEDEMA (Lymphedema on his right arm), LOCALISED INFECTION (Right arm became badly infected "It was a major infection"), PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Arm was red) and DIZZINESS (Dizziness) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included ACDF (Neck fusion Surgery).   On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced LOCALISED INFECTION (Right arm became badly infected "It was a major infection"), PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Arm was red), DIZZINESS (Dizziness), DYSPNOEA (Couldnt breathe), NECK PAIN (Back of his neck got really sore), VACCINATION SITE PAIN (Arm was sore at injection site), PYREXIA (Had a fever) and CHILLS (Chills). On an unknown date, the patient experienced LYMPHOEDEMA (Lymphedema on his right arm), MOBILITY DECREASED (Couldnt turn or raise his head up and down) and MYALGIA (Neck muscle pain.It is a constant lingering pain). The patient was treated with DEXTROMETHORPHAN (THERAFLU DX [DEXTROMETHORPHAN]) for Localised infection, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency; NAPROXEN SODIUM (ALEVE) for Neck pain, at an unspecified dose and frequency and Physical therapy (ice packs) for Localised infection. At the time of the report, LYMPHOEDEMA (Lymphedema on his right arm), LOCALISED INFECTION (Right arm became badly infected "It was a major infection"), PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Arm was red), DIZZINESS (Dizziness), DYSPNOEA (Couldnt breathe), MOBILITY DECREASED (Couldnt turn or raise his head up and down), NECK PAIN (Back of his neck got really sore), MYALGIA (Neck muscle pain.It is a constant lingering pain), VACCINATION SITE PAIN (Arm was sore at injection site), PYREXIA (Had a fever) and CHILLS (Chills) outcome was unknown.            Concomitant product information was not provided. Treatment information include ice packs.   Action taken with mRNA-1273 in response to events was not applicable.   This case was linked to MOD-2021-092604 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: No new information.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphoedema, Mobility decreased, Myalgia, Neck pain, Peripheral swelling
Clinical narrative: Lymphedema on his right arm; Neck muscle pain.It is a constant lingering pain; Couldnt turn or raise his head up and down; Back of his neck got really sore; Arm was sore at injection site; Had a fever; Chills; Right arm became badly infected "It was a major infection"; Arm was swollen; Arm was red; Dizziness; Couldnt breathe; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHOEDEMA (Lymphedema on his right arm), LOCALISED INFECTION (Right arm became badly infected "It was a major infection"), PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Arm was red) and DIZZINESS (Dizziness) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included ACDF (Neck fusion Surgery).   On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced LOCALISED INFECTION (Right arm became badly infected "It was a major infection"), PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Arm was red), DIZZINESS (Dizziness), DYSPNOEA (Couldnt breathe), NECK PAIN (Back of his neck got really sore), VACCINATION SITE PAIN (Arm was sore at injection site), PYREXIA (Had a fever) and CHILLS (Chills). On an unknown date, the patient experienced LYMPHOEDEMA (Lymphedema on his right arm), MOBILITY DECREASED (Couldnt turn or raise his head up and down) and MYALGIA (Neck muscle pain.It is a constant lingering pain). The patient was treated with DEXTROMETHORPHAN (THERAFLU DX [DEXTROMETHORPHAN]) for Localised infection, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency; NAPROXEN SODIUM (ALEVE) for Neck pain, at an unspecified dose and frequency and Physical therapy (ice packs) for Localised infection. At the time of the report, LYMPHOEDEMA (Lymphedema on his right arm), LOCALISED INFECTION (Right arm became badly infected "It was a major infection"), PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Arm was red), DIZZINESS (Dizziness), DYSPNOEA (Couldnt breathe), MOBILITY DECREASED (Couldnt turn or raise his head up and down), NECK PAIN (Back of his neck got really sore), MYALGIA (Neck muscle pain.It is a constant lingering pain), VACCINATION SITE PAIN (Arm was sore at injection site), PYREXIA (Had a fever) and CHILLS (Chills) outcome was unknown.            Concomitant product information was not provided. Treatment information include ice packs.   Action taken with mRNA-1273 in response to events was not applicable.   This case was linked to MOD-2021-092604 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: No new information.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Lymphedema on his right arm; Neck muscle pain.It is a constant lingering pain; Couldnt turn or raise his head up and down; Back of his neck got really sore; Arm was sore at injection site; Had a fever; Chills; Right arm became badly infected "It was a major infection"; Arm was swollen; Arm was red; Dizziness; Couldnt breathe; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHOEDEMA (Lymphedema on his right arm), LOCALISED INFECTION (Right arm became badly infected "It was a major infection"), PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Arm was red) and DIZZINESS (Dizziness) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included ACDF (Neck fusion Surgery).   On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced LOCALISED INFECTION (Right arm became badly infected "It was a major infection"), PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Arm was red), DIZZINESS (Dizziness), DYSPNOEA (Couldnt breathe), NECK PAIN (Back of his neck got really sore), VACCINATION SITE PAIN (Arm was sore at injection site), PYREXIA (Had a fever) and CHILLS (Chills). On an unknown date, the patient experienced LYMPHOEDEMA (Lymphedema on his right arm), MOBILITY DECREASED (Couldnt turn or raise his head up and down) and MYALGIA (Neck muscle pain.It is a constant lingering pain). The patient was treated with DEXTROMETHORPHAN (THERAFLU DX [DEXTROMETHORPHAN]) for Localised infection, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency; NAPROXEN SODIUM (ALEVE) for Neck pain, at an unspecified dose and frequency and Physical therapy (ice packs) for Localised infection. At the time of the report, LYMPHOEDEMA (Lymphedema on his right arm), LOCALISED INFECTION (Right arm became badly infected "It was a major infection"), PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Arm was red), DIZZINESS (Dizziness), DYSPNOEA (Couldnt breathe), MOBILITY DECREASED (Couldnt turn or raise his head up and down), NECK PAIN (Back of his neck got really sore), MYALGIA (Neck muscle pain.It is a constant lingering pain), VACCINATION SITE PAIN (Arm was sore at injection site), PYREXIA (Had a fever) and CHILLS (Chills) outcome was unknown.            Concomitant product information was not provided. Treatment information include ice packs.   Action taken with mRNA-1273 in response to events was not applicable.   This case was linked to MOD-2021-092604 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: No new information.